Drug Profile
Azilsartan trimethylethanolamine
Alternative Names: Azilsartan choline; Choline azilsartanLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Jiangsu Hansoh Pharmaceutical
- Class Antihypertensives; Benzimidazoles; Ethanolamines; Oxadiazoles; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Hypertension(In volunteers) in China (PO, Tablet)
- 11 Mar 2016 Phase-I development is ongoing in China
- 30 Sep 2013 Phase-I clinical trials in Hypertension (in volunteers) in China (PO)